Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
145.5 USD | -0.91% | -2.59% | -7.05% |
Apr. 29 | J&J, Bristol Myers lose challenges to US drug price negotiation program | RE |
Apr. 29 | J&J: positive CHMP opinion for lung cancer | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.05% | 354B | |
+35.45% | 664B | |
+28.45% | 567B | |
+19.62% | 330B | |
+3.61% | 286B | |
+13.45% | 234B | |
+4.98% | 199B | |
-10.14% | 196B | |
-5.26% | 148B | |
-10.78% | 145B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- BofA Securities Adjusts Price Target on Johnson & Johnson to $170 From $180, Maintains Neutral Rating